The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitini...

por McMullin, Mary Frances, Harrison, Claire N., Niederwieser, Dietger, Demuynck, Hilde, Jäkel, Nadja, Gopalakrishna, Prashanth, McQuitty, Mari, Stalbovskaya, Viktoriya, Recher, Christian, Theunissen, Koen, Gisslinger, Heinz, Kiladjian, Jean-Jacques, Al-Ali, Haifa-Kathrin
Publicado 2015